Detalles de la búsqueda
1.
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer.
J Transl Med
; 22(1): 195, 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388379
2.
Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer.
Future Oncol
; 19(19): 1367-1378, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37114967
3.
Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer.
Cancer Manag Res
; 15: 55-65, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36685716
4.
Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer.
Heliyon
; 9(6): e16483, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37251477
5.
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs.
Cancer Manag Res
; 15: 351-362, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37077536
6.
Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report.
Cancer Manag Res
; 14: 1595-1602, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35521088
7.
Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer.
Front Immunol
; 13: 931429, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36248782
8.
A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer.
Cancer Med
; 11(22): 4246-4255, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491970
Resultados
1 -
8
de 8
1
Próxima >
>>